| David D Hou, MD | |
|
100 Hitchcock Way, Manchester, NH 03104-4125 | |
| (603) 695-2850 | |
| Not Available |
| Full Name | David D Hou |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 100 Hitchcock Way, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629015409 | NPI | - | NPPES |
| 206029611 | Other | NH | TRICARE |
| 0166909 | Other | NH | CIGNA |
| 01Y010778NH01 | Other | NH | BLUE CROSS |
| 494986 | Other | NH | TUFTS |
| 30206000 | Medicaid | NH | |
| 7677803 | Other | NH | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 223775 (Massachusetts) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 13066 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
News Archive
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today results from a pre-clinical study show that the company's Tbit™ System for the detection of TBI is sensitive, provides actionable results in point-of-care settings, and has the potential to reduce the number of unnecessary computerized tomography (CT) scans.
Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
Joanna Fowler, a senior chemist and director of radiotracer chemistry, instrumentation, and biological imaging at the U.S. Department of Energy's Brookhaven National Laboratory, is one of 23 women from around the world who has been chosen to receive a Distinguished Women in Chemistry/Chemical Engineering Award, sponsored by the American Chemical Society (ACS).
› Verified 9 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today results from a pre-clinical study show that the company's Tbit™ System for the detection of TBI is sensitive, provides actionable results in point-of-care settings, and has the potential to reduce the number of unnecessary computerized tomography (CT) scans.
Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
Joanna Fowler, a senior chemist and director of radiotracer chemistry, instrumentation, and biological imaging at the U.S. Department of Energy's Brookhaven National Laboratory, is one of 23 women from around the world who has been chosen to receive a Distinguished Women in Chemistry/Chemical Engineering Award, sponsored by the American Chemical Society (ACS).
› Verified 9 days ago
| Entity Name | Littleton Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144223702 PECOS PAC ID: 6901796556 Enrollment ID: O20040322000785 |
News Archive
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today results from a pre-clinical study show that the company's Tbit™ System for the detection of TBI is sensitive, provides actionable results in point-of-care settings, and has the potential to reduce the number of unnecessary computerized tomography (CT) scans.
Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
Joanna Fowler, a senior chemist and director of radiotracer chemistry, instrumentation, and biological imaging at the U.S. Department of Energy's Brookhaven National Laboratory, is one of 23 women from around the world who has been chosen to receive a Distinguished Women in Chemistry/Chemical Engineering Award, sponsored by the American Chemical Society (ACS).
› Verified 9 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today results from a pre-clinical study show that the company's Tbit™ System for the detection of TBI is sensitive, provides actionable results in point-of-care settings, and has the potential to reduce the number of unnecessary computerized tomography (CT) scans.
Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
Joanna Fowler, a senior chemist and director of radiotracer chemistry, instrumentation, and biological imaging at the U.S. Department of Energy's Brookhaven National Laboratory, is one of 23 women from around the world who has been chosen to receive a Distinguished Women in Chemistry/Chemical Engineering Award, sponsored by the American Chemical Society (ACS).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David D Hou, MD 703 Riverway Pl, Bedford, NH 03110-6745 Ph: (603) 627-1661 | David D Hou, MD 100 Hitchcock Way, Manchester, NH 03104-4125 Ph: (603) 695-2850 |
News Archive
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today results from a pre-clinical study show that the company's Tbit™ System for the detection of TBI is sensitive, provides actionable results in point-of-care settings, and has the potential to reduce the number of unnecessary computerized tomography (CT) scans.
Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Historically, from the 1930's to the 1950's, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970's, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy.
Joanna Fowler, a senior chemist and director of radiotracer chemistry, instrumentation, and biological imaging at the U.S. Department of Energy's Brookhaven National Laboratory, is one of 23 women from around the world who has been chosen to receive a Distinguished Women in Chemistry/Chemical Engineering Award, sponsored by the American Chemical Society (ACS).
› Verified 9 days ago
Kevin Y Rivera Colon, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Dr. Bryan Parker Rowe, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Elliot Way, Manchester, NH 03103 Phone: 603-663-1800 | |
Dr. Charles George Leutzinger, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Elliot Way, Manchester, NH 03103 Phone: 603-663-2361 Fax: 603-668-4303 | |
G. Eric Geslien, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-629-1877 Fax: 603-695-2856 | |
Dr. James David Becht, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Elliot Way, Radiation Oncology Department, Manchester, NH 03103 Phone: 603-663-1800 Fax: 603-668-4303 | |
Dr. Brian Robert Knab, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Elliot Way, Manchester, NH 03103 Phone: 603-663-1800 Fax: 603-663-1807 | |
Dr. Kathleen Meghan Doherty, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Elliot Breast Health Center, 185 Queen City Ave, Manchester, NH 03101 Phone: 603-663-2204 |